cagrilintide clinical trials Trial Scorecard: REDEFINE 1 and 2 CagriSema vs tirzepatide: which next-generation

PMID: 220 SatoKHallCGlaserSFrancisHMengFAlpiniG

If studies looking at FTD could investigate the occurrence of microbes om FTD only patients (without comorbid AD) brain regions and determine the existence or lack thereof of key AD related microbes, it could help better define the difference between these related dementias

A personal dose would need to account for diagnosis, other medicines, allergies, pregnancy status, kidney or liver disease, substance use, and the exact product being used

287 ZhangL.DaiL.LiD

These include: Mild nausea or digestive discomfort (more common with oral forms) Dizziness or lightheadedness Injection site irritation, redness, or swelling Possible changes in appetite These side effects typically go away on their own and do not pose long-term risks